Aveanna Healthcare's Stock Falls 8% Following Announcement of 10M Share Secondary Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 22 2025
0mins
Should l Buy AVAH?
Source: SeekingAlpha
Secondary Offering Announcement: Aveanna Healthcare has priced a secondary offering of 10 million shares at $9.00 each, with selling stockholders receiving all net proceeds.
Underwriters' Option: The underwriters have a 30-day option to purchase an additional 1.5 million shares as part of the offering.
Settlement Date: The offering is expected to settle on October 23.
Stock Price Reaction: Following the announcement, Aveanna's stock price fell by 8% during after-market trading on Tuesday.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AVAH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AVAH
Wall Street analysts forecast AVAH stock price to rise
5 Analyst Rating
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 6.940
Low
10.00
Averages
10.75
High
11.00
Current: 6.940
Low
10.00
Averages
10.75
High
11.00
About AVAH
Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. Its segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. It also provides case management services to assist families and patients by coordinating the provision of services between insurers and other healthcare providers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Summit Partners Sells Aveanna Healthcare Shares Worth $16.23 Million
- Share Sale Details: In Q1 2026, Summit Partners sold 2.1 million shares of Aveanna Healthcare, with an estimated trade value of $16.23 million, reflecting its ongoing investment strategy in the company.
- Asset Management Impact: This transaction resulted in a 2.42% decrease in the fund's reportable assets under management (AUM), while the quarter-end position value declined by $26.62 million, indicating the impact of market volatility on its portfolio.
- Company Performance Highlights: Aveanna Healthcare achieved a 20.2% revenue growth in 2025, reaching $2.43 billion, with adjusted EBITDA surging nearly 75% to $320.9 million, demonstrating strong operational performance despite shareholder sell-off.
- Market Consolidation Strategy: Aveanna is consolidating the fragmented home healthcare market through acquisitions, including a planned $175.5 million deal for Family First Homecare, expected to close this quarter, showcasing its long-term strategic intent to scale.
See More
Summit Partners Sells Shares of Aveanna Healthcare
- Share Sale Overview: On May 8, 2026, Summit Partners disclosed in an SEC filing the sale of 2.1 million shares of Aveanna Healthcare, valued at approximately $16.23 million, indicating a continued strategy of reducing its stake in the company.
- Asset Management Impact: The share sale resulted in a $26.62 million decline in Summit Partners' quarter-end position value, reflecting the sensitivity of the market to Aveanna Healthcare's stock price fluctuations, while the company's stake now represents 5.23% of reported assets under management.
- Company Performance Highlights: Aveanna Healthcare achieved a 20.2% revenue increase in 2025, reaching $2.43 billion, with adjusted EBITDA surging nearly 75% to $320.9 million, showcasing strong operational performance and sustained market demand.
- Market Consolidation Strategy: Aveanna is consolidating the fragmented home healthcare market through acquisitions, including a planned $175.5 million deal for Family First Homecare expected to close this quarter, with future focus on translating growth into stronger margins and cash flow.
See More
Aveanna Healthcare to Attend Barclays Leveraged Finance Conference
- Management Attendance: Aveanna Healthcare announced that its management team will attend the Barclays 30th Annual Leveraged Finance Conference in Austin, TX on May 19, 2026, planning to host one-on-one investor meetings to enhance engagement and boost company visibility.
- Broad Service Range: Aveanna operates in 38 states, offering a wide array of healthcare services including nursing, rehabilitation, occupational nursing, therapy services, and home health, aiming to provide high-quality, lower-cost alternatives to prolonged hospitalization, thereby improving patient quality of life.
- Case Management Services: The company also provides case management services to assist families and patients in coordinating services among insurers, physicians, hospitals, and other healthcare providers, ensuring comprehensive medical support and enhancing its competitive position in the healthcare market.
- Respite Care Services: Aveanna's respite care services offer temporary relief for regular caregivers, alleviating their burden and demonstrating the company's commitment to supporting patients and their families, which in turn strengthens customer loyalty.
See More
Aveanna Healthcare to Release Q1 Results
- Earnings Release Schedule: Aveanna Healthcare will announce its Q1 financial results before market open on May 14, 2026, followed by a conference call at 10:00 a.m. ET, reflecting the company's commitment to transparency and investor communication.
- Conference Call Access: Investors can join the call by dialing 1-877-407-0789 (international callers: 1-201-689-8562), with a replay available three hours post-call until May 21, ensuring timely access to critical information for stakeholders.
- Webcast Option: The call will also be available via a live webcast on the company's Investor Relations website, with the replay accessible for one week after the event, enhancing information accessibility and transparency for investors.
- Company Overview: Headquartered in Atlanta, Georgia, Aveanna Healthcare offers a wide range of services including nursing, rehabilitation, and home health care, aiming to provide high-quality, lower-cost alternatives to prolonged hospitalization, showcasing the company's diversity and expertise in the healthcare sector.
See More
Aveanna Healthcare Reports Strong Q4 2025 Earnings with Strategic Growth Plans
- Significant Revenue Growth: Aveanna Healthcare reported approximately $662.5 million in Q4 2025 revenue, marking a 27.4% year-over-year increase, with full-year revenue reaching about $2.433 billion, showcasing the company's strong growth potential under its preferred payer strategy.
- Outstanding EBITDA Performance: The adjusted EBITDA for Q4 was $85 million, up 54% year-over-year, reflecting the company's success in operational efficiency and cost control, with expectations for 2026 EBITDA to remain between $318 million and $322 million.
- Acquisition Plans Advancing: The company announced the acquisition of Family First Homecare, expected to close in Q2 2026, which is anticipated to enhance its market presence in Florida, alongside plans to add eight new preferred payer agreements in 2026, targeting a total of 38 by year-end.
- Optimistic Future Outlook: Management projects 2026 revenue in the range of $2.54 billion to $2.56 billion, emphasizing a continued focus on technology investments and operational efficiency to support future growth strategies.
See More
Aveanna Healthcare Shares Plunge 10% After Q4 Results
- Significant Stock Drop: Aveanna Healthcare (AVAH) shares fell approximately 10% on Thursday, marking its largest intraday decline in over a year, primarily due to its 2026 revenue outlook missing the midpoint of market consensus.
- Revenue Guidance Maintained: Although the company maintained its 2026 revenue guidance between $2.54 billion and $2.56 billion, this forecast falls short of analysts' expectations of $2.56 billion, reflecting market concerns about future growth.
- Earnings Beat Expectations: Aveanna's Q4 2025 revenue grew approximately 27% year-over-year to $662.5 million, driving full-year revenue up about 20% to $2.4 billion, indicating strong performance in the market.
- Adjusted EBITDA Surge: The adjusted EBITDA for Q4 increased roughly 54% year-over-year to $85 million, exceeding the consensus estimate of $78.8 million, while the full-year adjusted EBITDA jumped about 75% to $320.9 million, showcasing a significant improvement in the company's profitability.
See More
Summit Partners Sells Aveanna Healthcare Shares Worth $16.23 Million
- Share Sale Details: In Q1 2026, Summit Partners sold 2.1 million shares of Aveanna Healthcare, with an estimated trade value of $16.23 million, reflecting its ongoing investment strategy in the company.
- Asset Management Impact: This transaction resulted in a 2.42% decrease in the fund's reportable assets under management (AUM), while the quarter-end position value declined by $26.62 million, indicating the impact of market volatility on its portfolio.
- Company Performance Highlights: Aveanna Healthcare achieved a 20.2% revenue growth in 2025, reaching $2.43 billion, with adjusted EBITDA surging nearly 75% to $320.9 million, demonstrating strong operational performance despite shareholder sell-off.
- Market Consolidation Strategy: Aveanna is consolidating the fragmented home healthcare market through acquisitions, including a planned $175.5 million deal for Family First Homecare, expected to close this quarter, showcasing its long-term strategic intent to scale.
See More
Summit Partners Sells Shares of Aveanna Healthcare
- Share Sale Overview: On May 8, 2026, Summit Partners disclosed in an SEC filing the sale of 2.1 million shares of Aveanna Healthcare, valued at approximately $16.23 million, indicating a continued strategy of reducing its stake in the company.
- Asset Management Impact: The share sale resulted in a $26.62 million decline in Summit Partners' quarter-end position value, reflecting the sensitivity of the market to Aveanna Healthcare's stock price fluctuations, while the company's stake now represents 5.23% of reported assets under management.
- Company Performance Highlights: Aveanna Healthcare achieved a 20.2% revenue increase in 2025, reaching $2.43 billion, with adjusted EBITDA surging nearly 75% to $320.9 million, showcasing strong operational performance and sustained market demand.
- Market Consolidation Strategy: Aveanna is consolidating the fragmented home healthcare market through acquisitions, including a planned $175.5 million deal for Family First Homecare expected to close this quarter, with future focus on translating growth into stronger margins and cash flow.
See More
Aveanna Healthcare to Attend Barclays Leveraged Finance Conference
- Management Attendance: Aveanna Healthcare announced that its management team will attend the Barclays 30th Annual Leveraged Finance Conference in Austin, TX on May 19, 2026, planning to host one-on-one investor meetings to enhance engagement and boost company visibility.
- Broad Service Range: Aveanna operates in 38 states, offering a wide array of healthcare services including nursing, rehabilitation, occupational nursing, therapy services, and home health, aiming to provide high-quality, lower-cost alternatives to prolonged hospitalization, thereby improving patient quality of life.
- Case Management Services: The company also provides case management services to assist families and patients in coordinating services among insurers, physicians, hospitals, and other healthcare providers, ensuring comprehensive medical support and enhancing its competitive position in the healthcare market.
- Respite Care Services: Aveanna's respite care services offer temporary relief for regular caregivers, alleviating their burden and demonstrating the company's commitment to supporting patients and their families, which in turn strengthens customer loyalty.
See More
Aveanna Healthcare to Release Q1 Results
- Earnings Release Schedule: Aveanna Healthcare will announce its Q1 financial results before market open on May 14, 2026, followed by a conference call at 10:00 a.m. ET, reflecting the company's commitment to transparency and investor communication.
- Conference Call Access: Investors can join the call by dialing 1-877-407-0789 (international callers: 1-201-689-8562), with a replay available three hours post-call until May 21, ensuring timely access to critical information for stakeholders.
- Webcast Option: The call will also be available via a live webcast on the company's Investor Relations website, with the replay accessible for one week after the event, enhancing information accessibility and transparency for investors.
- Company Overview: Headquartered in Atlanta, Georgia, Aveanna Healthcare offers a wide range of services including nursing, rehabilitation, and home health care, aiming to provide high-quality, lower-cost alternatives to prolonged hospitalization, showcasing the company's diversity and expertise in the healthcare sector.
See More
Aveanna Healthcare Reports Strong Q4 2025 Earnings with Strategic Growth Plans
- Significant Revenue Growth: Aveanna Healthcare reported approximately $662.5 million in Q4 2025 revenue, marking a 27.4% year-over-year increase, with full-year revenue reaching about $2.433 billion, showcasing the company's strong growth potential under its preferred payer strategy.
- Outstanding EBITDA Performance: The adjusted EBITDA for Q4 was $85 million, up 54% year-over-year, reflecting the company's success in operational efficiency and cost control, with expectations for 2026 EBITDA to remain between $318 million and $322 million.
- Acquisition Plans Advancing: The company announced the acquisition of Family First Homecare, expected to close in Q2 2026, which is anticipated to enhance its market presence in Florida, alongside plans to add eight new preferred payer agreements in 2026, targeting a total of 38 by year-end.
- Optimistic Future Outlook: Management projects 2026 revenue in the range of $2.54 billion to $2.56 billion, emphasizing a continued focus on technology investments and operational efficiency to support future growth strategies.
See More
Aveanna Healthcare Shares Plunge 10% After Q4 Results
- Significant Stock Drop: Aveanna Healthcare (AVAH) shares fell approximately 10% on Thursday, marking its largest intraday decline in over a year, primarily due to its 2026 revenue outlook missing the midpoint of market consensus.
- Revenue Guidance Maintained: Although the company maintained its 2026 revenue guidance between $2.54 billion and $2.56 billion, this forecast falls short of analysts' expectations of $2.56 billion, reflecting market concerns about future growth.
- Earnings Beat Expectations: Aveanna's Q4 2025 revenue grew approximately 27% year-over-year to $662.5 million, driving full-year revenue up about 20% to $2.4 billion, indicating strong performance in the market.
- Adjusted EBITDA Surge: The adjusted EBITDA for Q4 increased roughly 54% year-over-year to $85 million, exceeding the consensus estimate of $78.8 million, while the full-year adjusted EBITDA jumped about 75% to $320.9 million, showcasing a significant improvement in the company's profitability.
See More
